RLEFX
Price
$38.98
Change
+$0.04 (+0.10%)
Updated
Oct 17 closing price
Net Assets
265.37B
TPPAX
Price
$26.21
Change
+$0.04 (+0.15%)
Updated
Oct 17 closing price
Net Assets
2.07B
Interact to see
Advertisement

RLEFX vs TPPAX

Header iconRLEFX vs TPPAX Comparison
Open Charts RLEFX vs TPPAXBanner chart's image
American Funds American Balanced R5E
Price$38.98
Change+$0.04 (+0.10%)
VolumeN/A
Net Assets265.37B
T. Rowe Price Spectrum Moderate Allc I
Price$26.21
Change+$0.04 (+0.15%)
VolumeN/A
Net Assets2.07B
RLEFX vs TPPAX Comparison Chart in %
View a ticker or compare two or three
VS
RLEFX vs. TPPAX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLEFX is a Buy and TPPAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 265B vs. TPPAX (2.07B). TPPAX pays higher dividends than RLEFX: TPPAX (2.43) vs RLEFX (1.92). RLEFX was incepted earlier than TPPAX: RLEFX (10 years) vs TPPAX (10 years). TPPAX (0.80) is less costly to investors than RLEFX (0.39). TPPAX (45.00) and RLEFX (44.00) have comparable annual turnover. RLEFX has a lower initial minimum investment than TPPAX: RLEFX (250) vs TPPAX (500000). RLEFX annual gain was more profitable for investors over the last year : 8.94 vs. TPPAX (5.97). RLEFX return over 5 years is better than : 43.26 vs. TPPAX (12.99).
RLEFXTPPAXRLEFX / TPPAX
Total Expense Ratio0.390.6263%
Annual Report Gross Expense Ratio0.390.8049%
Fund Existence10 years10 years-
Gain YTD14.81912.009123%
Front LoadN/AN/A-
Min. Initial Investment2505000000%
Min. Initial Investment IRAN/AN/A-
Net Assets265B2.07B12,827%
Annual Yield % from dividends1.922.4379%
Returns for 1 year8.945.97150%
Returns for 3 years51.3934.54149%
Returns for 5 years43.2612.99333%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COEP15.380.38
+2.53%
Coeptis Therapeutics Holdings Inc
STC69.760.91
+1.32%
Stewart Information Services Corp
ATMVU22.00N/A
N/A
AlphaVest Acquisition Corp
BBIO54.92-0.11
-0.20%
BridgeBio Pharma
SRTA4.99-0.09
-1.77%
Strata Critical Medical Inc